[RNAZ] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
29-Sep-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -22.06%
YoY- -23.54%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 753 0 0 0 0 -
PBT -5,191 -3,327 -4,088 -5,300 -4,342 -4,817 -5,134 0.73%
Tax 0 -179 -0 27 789 -5 13,275 -
NP -5,191 -3,327 -4,088 -5,300 -4,342 -4,812 -18,409 -57.03%
Tax Rate - - - - - - - -
Total Cost 5,191 3,327 4,841 5,300 4,342 4,812 18,409 -57.03%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -542.73 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.74 -0.65 -22.83 -67.95 -135.68 -267.34 -1,134.84 -99.25%
EPS Diluted -0.74 -0.65 -22.83 -67.15 -131.61 -267.34 -1,134.84 -99.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.